Please use this identifier to cite or link to this item:
Title: Final results from PAVES, a phase 3, randomized, double-blind, placebo-controlled trial of pegfilgrastim in patients (pts) receiving first-line FOLFOX or FOLFIRI and bevacizumab for locally advanced or metastatic colorectal cancer (LA/mCRC) (NCT00911170)
Authors: Готько, Євген Степанович
T. Pinter P.K. Morrow A. Cesas A. Croitoru J. Decaestecker P. Gibbs
J. Jassem G. Kurteva J. Novotny S. O'Reilly T. Salek L. Khosrowshahi M. Reiner Z. Klippel C. Blanke
Issue Date: 2015
Publisher: Gastroentérologie Clinique et Biologique Vol 33, N° HS1 - mars 2009 p. 139
Type: Text
Publication type: Стаття
Appears in Collections:Наукові публікації кафедри радіології та онкології

Files in This Item:
File Description SizeFormat 
main.pdf.png214.81 kBimage/pngView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.